Does ROSUVASTATIN Cause Haemodynamic instability? 23 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Haemodynamic instability have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.1% of all adverse event reports for ROSUVASTATIN.
23
Reports of Haemodynamic instability with ROSUVASTATIN
0.1%
of all ROSUVASTATIN reports
4
Deaths
20
Hospitalizations
How Dangerous Is Haemodynamic instability From ROSUVASTATIN?
Of the 23 reports, 4 (17.4%) resulted in death, 20 (87.0%) required hospitalization, and 2 (8.7%) were considered life-threatening.
Is Haemodynamic instability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Haemodynamic instability?
METFORMIN (371)
AMLODIPINE (335)
TACROLIMUS (197)
DEXAMETHASONE (185)
ACETAMINOPHEN (184)
PROPOFOL (182)
VANCOMYCIN (171)
PREDNISONE (156)
MYCOPHENOLATE MOFETIL (142)
METHYLPREDNISOLONE (137)
Which ROSUVASTATIN Alternatives Have Lower Haemodynamic instability Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN